Cargando…
Expression and Prognostic Value of PIK3CA, VEGF, IL-8, IL-10, and RIP2 in Diffuse Large B-Cell Lymphoma
BACKGROUND: To explore clinical features and prognostic value of vascular endothelial growth factor (VEGF), interleukin (IL) 8, IL-10, phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA), and receptor-interacting protein-2 (RIP2) in diffuse large B-cell lymphoma (DLBCL)....
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750766/ https://www.ncbi.nlm.nih.gov/pubmed/36567775 http://dx.doi.org/10.1155/2022/2637581 |
_version_ | 1784850329040322560 |
---|---|
author | Shen, Na Yu, Yanfang Zhang, Ruiying Guo, Ying Liu, Mei Tan, Mengtian Liu, Jianxia Bai, Jing Li, Li Liu, Keyu Wang, Ran He, Jinglan |
author_facet | Shen, Na Yu, Yanfang Zhang, Ruiying Guo, Ying Liu, Mei Tan, Mengtian Liu, Jianxia Bai, Jing Li, Li Liu, Keyu Wang, Ran He, Jinglan |
author_sort | Shen, Na |
collection | PubMed |
description | BACKGROUND: To explore clinical features and prognostic value of vascular endothelial growth factor (VEGF), interleukin (IL) 8, IL-10, phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA), and receptor-interacting protein-2 (RIP2) in diffuse large B-cell lymphoma (DLBCL). METHODS: A total of 68 DLBCL patients admitted to the Affiliated Hospital of Hebei Engineering University from January 2017 to June 2021 were included in this retrospective analysis. Serum VEGF was detected by enzyme-linked immunosorbent assay, serum IL-8 and IL-10 were detected by chemiluminescent enzyme immunoassay, and expression of PIK3CA and RIP2 in tumors was detected by immunohistochemistry. The correlation between clinical features of DLBCL and tumor-related index were analyzed. Cox regression was conducted to explore risk factors and hazard ratio. RESULTS: The serum level or expressions of VEGF, IL-8, IL-10, and RIP2 were significantly elevated with the increase of Ann Arbor Stage, International Prognostic Index (IPI) scores, Eastern Cooperative Oncology Group (ECOG) scores, serum lactate dehydrogenase (LDH) level, and the number of extranodal sites (all P < 0.05). Beside, these serum indexes were significantly higher in patients with the presence of extranodal involvement and germinal center B-cell (GCB), but significantly lower in patients with the presence of bone marrow involvement (all P < 0.05). Cox regression analysis for overall survival revealed that high expression of VEGF, high level of serum IL-8, serum IL-10, and RIP2, Ann Arbor Stage (III-IV), number of extranodal sites (>1), serum LDH level (≥245 U/L), IPI scores (3–5), ECOG scores (≥2), and bone marrow involvement were independent risk factors for the prognosis of DLBCL patients (all P < 0.05). CONCLUSION: The serum levels of VEGF, IL-8, and IL-10, as well as the expression of RIP2 and PIK3CA in tumor tissues, were highly correlated to clinical features of DLBCL, and high expression level of these indexes may have adverse effects for the prognosis of DLBCL patients. |
format | Online Article Text |
id | pubmed-9750766 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-97507662022-12-23 Expression and Prognostic Value of PIK3CA, VEGF, IL-8, IL-10, and RIP2 in Diffuse Large B-Cell Lymphoma Shen, Na Yu, Yanfang Zhang, Ruiying Guo, Ying Liu, Mei Tan, Mengtian Liu, Jianxia Bai, Jing Li, Li Liu, Keyu Wang, Ran He, Jinglan Int J Clin Pract Research Article BACKGROUND: To explore clinical features and prognostic value of vascular endothelial growth factor (VEGF), interleukin (IL) 8, IL-10, phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA), and receptor-interacting protein-2 (RIP2) in diffuse large B-cell lymphoma (DLBCL). METHODS: A total of 68 DLBCL patients admitted to the Affiliated Hospital of Hebei Engineering University from January 2017 to June 2021 were included in this retrospective analysis. Serum VEGF was detected by enzyme-linked immunosorbent assay, serum IL-8 and IL-10 were detected by chemiluminescent enzyme immunoassay, and expression of PIK3CA and RIP2 in tumors was detected by immunohistochemistry. The correlation between clinical features of DLBCL and tumor-related index were analyzed. Cox regression was conducted to explore risk factors and hazard ratio. RESULTS: The serum level or expressions of VEGF, IL-8, IL-10, and RIP2 were significantly elevated with the increase of Ann Arbor Stage, International Prognostic Index (IPI) scores, Eastern Cooperative Oncology Group (ECOG) scores, serum lactate dehydrogenase (LDH) level, and the number of extranodal sites (all P < 0.05). Beside, these serum indexes were significantly higher in patients with the presence of extranodal involvement and germinal center B-cell (GCB), but significantly lower in patients with the presence of bone marrow involvement (all P < 0.05). Cox regression analysis for overall survival revealed that high expression of VEGF, high level of serum IL-8, serum IL-10, and RIP2, Ann Arbor Stage (III-IV), number of extranodal sites (>1), serum LDH level (≥245 U/L), IPI scores (3–5), ECOG scores (≥2), and bone marrow involvement were independent risk factors for the prognosis of DLBCL patients (all P < 0.05). CONCLUSION: The serum levels of VEGF, IL-8, and IL-10, as well as the expression of RIP2 and PIK3CA in tumor tissues, were highly correlated to clinical features of DLBCL, and high expression level of these indexes may have adverse effects for the prognosis of DLBCL patients. Hindawi 2022-12-07 /pmc/articles/PMC9750766/ /pubmed/36567775 http://dx.doi.org/10.1155/2022/2637581 Text en Copyright © 2022 Na Shen et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Shen, Na Yu, Yanfang Zhang, Ruiying Guo, Ying Liu, Mei Tan, Mengtian Liu, Jianxia Bai, Jing Li, Li Liu, Keyu Wang, Ran He, Jinglan Expression and Prognostic Value of PIK3CA, VEGF, IL-8, IL-10, and RIP2 in Diffuse Large B-Cell Lymphoma |
title | Expression and Prognostic Value of PIK3CA, VEGF, IL-8, IL-10, and RIP2 in Diffuse Large B-Cell Lymphoma |
title_full | Expression and Prognostic Value of PIK3CA, VEGF, IL-8, IL-10, and RIP2 in Diffuse Large B-Cell Lymphoma |
title_fullStr | Expression and Prognostic Value of PIK3CA, VEGF, IL-8, IL-10, and RIP2 in Diffuse Large B-Cell Lymphoma |
title_full_unstemmed | Expression and Prognostic Value of PIK3CA, VEGF, IL-8, IL-10, and RIP2 in Diffuse Large B-Cell Lymphoma |
title_short | Expression and Prognostic Value of PIK3CA, VEGF, IL-8, IL-10, and RIP2 in Diffuse Large B-Cell Lymphoma |
title_sort | expression and prognostic value of pik3ca, vegf, il-8, il-10, and rip2 in diffuse large b-cell lymphoma |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750766/ https://www.ncbi.nlm.nih.gov/pubmed/36567775 http://dx.doi.org/10.1155/2022/2637581 |
work_keys_str_mv | AT shenna expressionandprognosticvalueofpik3cavegfil8il10andrip2indiffuselargebcelllymphoma AT yuyanfang expressionandprognosticvalueofpik3cavegfil8il10andrip2indiffuselargebcelllymphoma AT zhangruiying expressionandprognosticvalueofpik3cavegfil8il10andrip2indiffuselargebcelllymphoma AT guoying expressionandprognosticvalueofpik3cavegfil8il10andrip2indiffuselargebcelllymphoma AT liumei expressionandprognosticvalueofpik3cavegfil8il10andrip2indiffuselargebcelllymphoma AT tanmengtian expressionandprognosticvalueofpik3cavegfil8il10andrip2indiffuselargebcelllymphoma AT liujianxia expressionandprognosticvalueofpik3cavegfil8il10andrip2indiffuselargebcelllymphoma AT baijing expressionandprognosticvalueofpik3cavegfil8il10andrip2indiffuselargebcelllymphoma AT lili expressionandprognosticvalueofpik3cavegfil8il10andrip2indiffuselargebcelllymphoma AT liukeyu expressionandprognosticvalueofpik3cavegfil8il10andrip2indiffuselargebcelllymphoma AT wangran expressionandprognosticvalueofpik3cavegfil8il10andrip2indiffuselargebcelllymphoma AT hejinglan expressionandprognosticvalueofpik3cavegfil8il10andrip2indiffuselargebcelllymphoma |